Ono K

References (24)

Title : Baseline characteristics of patients with early Alzheimer's disease enrolled in the pivotal trial of low-intensity pulsed ultrasound (LIPUS-AD) - Shimokawa_2025_J.Alzheimers.Dis.Rep_9_25424823251407541
Author(s) : Shimokawa H , Akishita M , Asada T , Katayama S , Hattori Y , Yakushiji Y , Taki Y , Murai H , Boku Y , Tsujimoto M , Umegaki H , Ogawa T , Matsumoto S , Ono K , Imon Y , Tsunemi T , Iwata A , Hanajima R , Hisahara S , Uehara T , Ishiguro T , Nakaoku Y , Ishii K , Ishiki A , Nagai Y , Teramukai S , Ihara M , Fukushima M
Ref : J Alzheimers Dis Rep , 9 :25424823251407541 , 2025
Abstract :
PubMedSearch : Shimokawa_2025_J.Alzheimers.Dis.Rep_9_25424823251407541
PubMedID: 41477670

Title : Baseline characteristics of patients with early Alzheimer's disease enrolled in the pivotal trial of low-intensity pulsed ultrasound (LIPUS-AD) - Shimokawa_2025_J.Alzheimers.Dis.Rep_9_25424823251407541
Author(s) : Shimokawa H , Akishita M , Asada T , Katayama S , Hattori Y , Yakushiji Y , Taki Y , Murai H , Boku Y , Tsujimoto M , Umegaki H , Ogawa T , Matsumoto S , Ono K , Imon Y , Tsunemi T , Iwata A , Hanajima R , Hisahara S , Uehara T , Ishiguro T , Nakaoku Y , Ishii K , Ishiki A , Nagai Y , Teramukai S , Ihara M , Fukushima M
Ref : J Alzheimers Dis Rep , 9 :25424823251407541 , 2025
Abstract :
PubMedSearch : Shimokawa_2025_J.Alzheimers.Dis.Rep_9_25424823251407541
PubMedID: 41477670

Title : Baseline characteristics of patients with early Alzheimer's disease enrolled in the pivotal trial of low-intensity pulsed ultrasound (LIPUS-AD) - Shimokawa_2025_J.Alzheimers.Dis.Rep_9_25424823251407541
Author(s) : Shimokawa H , Akishita M , Asada T , Katayama S , Hattori Y , Yakushiji Y , Taki Y , Murai H , Boku Y , Tsujimoto M , Umegaki H , Ogawa T , Matsumoto S , Ono K , Imon Y , Tsunemi T , Iwata A , Hanajima R , Hisahara S , Uehara T , Ishiguro T , Nakaoku Y , Ishii K , Ishiki A , Nagai Y , Teramukai S , Ihara M , Fukushima M
Ref : J Alzheimers Dis Rep , 9 :25424823251407541 , 2025
Abstract :
PubMedSearch : Shimokawa_2025_J.Alzheimers.Dis.Rep_9_25424823251407541
PubMedID: 41477670

Title : An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's disease - Kainuma_2022_Front.Pharmacol_13_991982
Author(s) : Kainuma M , Ouma S , Kawakatsu S , Iritani O , Yamashita KI , Ohara T , Hirano S , Suda S , Hamano T , Hieda S , Yasui M , Yoshiiwa A , Shiota S , Hironishi M , Wada-Isoe K , Sasabayashi D , Yamasaki S , Murata M , Funakoshi K , Hayashi K , Shirafuji N , Sasaki H , Kajimoto Y , Mori Y , Suzuki M , Ito H , Ono K , Tsuboi Y
Ref : Front Pharmacol , 13 :991982 , 2022
Abstract :
PubMedSearch : Kainuma_2022_Front.Pharmacol_13_991982
PubMedID: 36313371

Title : An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's disease - Kainuma_2022_Front.Pharmacol_13_991982
Author(s) : Kainuma M , Ouma S , Kawakatsu S , Iritani O , Yamashita KI , Ohara T , Hirano S , Suda S , Hamano T , Hieda S , Yasui M , Yoshiiwa A , Shiota S , Hironishi M , Wada-Isoe K , Sasabayashi D , Yamasaki S , Murata M , Funakoshi K , Hayashi K , Shirafuji N , Sasaki H , Kajimoto Y , Mori Y , Suzuki M , Ito H , Ono K , Tsuboi Y
Ref : Front Pharmacol , 13 :991982 , 2022
Abstract :
PubMedSearch : Kainuma_2022_Front.Pharmacol_13_991982
PubMedID: 36313371

Title : An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's disease - Kainuma_2022_Front.Pharmacol_13_991982
Author(s) : Kainuma M , Ouma S , Kawakatsu S , Iritani O , Yamashita KI , Ohara T , Hirano S , Suda S , Hamano T , Hieda S , Yasui M , Yoshiiwa A , Shiota S , Hironishi M , Wada-Isoe K , Sasabayashi D , Yamasaki S , Murata M , Funakoshi K , Hayashi K , Shirafuji N , Sasaki H , Kajimoto Y , Mori Y , Suzuki M , Ito H , Ono K , Tsuboi Y
Ref : Front Pharmacol , 13 :991982 , 2022
Abstract :
PubMedSearch : Kainuma_2022_Front.Pharmacol_13_991982
PubMedID: 36313371

Title : Pharmacological Potential of Cilostazol for Alzheimer's Disease - Ono_2019_Front.Pharmacol_10_559
Author(s) : Ono K , Tsuji M
Ref : Front Pharmacol , 10 :559 , 2019
Abstract :
PubMedSearch : Ono_2019_Front.Pharmacol_10_559
PubMedID: 31191308

Title : Pharmacological Potential of Cilostazol for Alzheimer's Disease - Ono_2019_Front.Pharmacol_10_559
Author(s) : Ono K , Tsuji M
Ref : Front Pharmacol , 10 :559 , 2019
Abstract :
PubMedSearch : Ono_2019_Front.Pharmacol_10_559
PubMedID: 31191308

Title : Pharmacological Potential of Cilostazol for Alzheimer's Disease - Ono_2019_Front.Pharmacol_10_559
Author(s) : Ono K , Tsuji M
Ref : Front Pharmacol , 10 :559 , 2019
Abstract :
PubMedSearch : Ono_2019_Front.Pharmacol_10_559
PubMedID: 31191308

Title : Supratherapeutic concentrations of cilostazol inhibits beta-amyloid oligomerization in vitro - Shozawa_2018_Neurosci.Lett_677_19
Author(s) : Shozawa H , Oguchi T , Tsuji M , Yano S , Kiuchi Y , Ono K
Ref : Neuroscience Letters , 677 :19 , 2018
Abstract :
PubMedSearch : Shozawa_2018_Neurosci.Lett_677_19
PubMedID: 29684530

Title : Supratherapeutic concentrations of cilostazol inhibits beta-amyloid oligomerization in vitro - Shozawa_2018_Neurosci.Lett_677_19
Author(s) : Shozawa H , Oguchi T , Tsuji M , Yano S , Kiuchi Y , Ono K
Ref : Neuroscience Letters , 677 :19 , 2018
Abstract :
PubMedSearch : Shozawa_2018_Neurosci.Lett_677_19
PubMedID: 29684530

Title : Supratherapeutic concentrations of cilostazol inhibits beta-amyloid oligomerization in vitro - Shozawa_2018_Neurosci.Lett_677_19
Author(s) : Shozawa H , Oguchi T , Tsuji M , Yano S , Kiuchi Y , Ono K
Ref : Neuroscience Letters , 677 :19 , 2018
Abstract :
PubMedSearch : Shozawa_2018_Neurosci.Lett_677_19
PubMedID: 29684530

Title : Cilostazol Suppresses Abeta-induced Neurotoxicity in SH-SY5Y Cells through Inhibition of Oxidative Stress and MAPK Signaling Pathway - Oguchi_2017_Front.Aging.Neurosci_9_337
Author(s) : Oguchi T , Ono R , Tsuji M , Shozawa H , Somei M , Inagaki M , Mori Y , Yasumoto T , Ono K , Kiuchi Y
Ref : Front Aging Neurosci , 9 :337 , 2017
Abstract :
PubMedSearch : Oguchi_2017_Front.Aging.Neurosci_9_337
PubMedID: 29089887

Title : Cilostazol Suppresses Abeta-induced Neurotoxicity in SH-SY5Y Cells through Inhibition of Oxidative Stress and MAPK Signaling Pathway - Oguchi_2017_Front.Aging.Neurosci_9_337
Author(s) : Oguchi T , Ono R , Tsuji M , Shozawa H , Somei M , Inagaki M , Mori Y , Yasumoto T , Ono K , Kiuchi Y
Ref : Front Aging Neurosci , 9 :337 , 2017
Abstract :
PubMedSearch : Oguchi_2017_Front.Aging.Neurosci_9_337
PubMedID: 29089887

Title : Cilostazol Suppresses Abeta-induced Neurotoxicity in SH-SY5Y Cells through Inhibition of Oxidative Stress and MAPK Signaling Pathway - Oguchi_2017_Front.Aging.Neurosci_9_337
Author(s) : Oguchi T , Ono R , Tsuji M , Shozawa H , Somei M , Inagaki M , Mori Y , Yasumoto T , Ono K , Kiuchi Y
Ref : Front Aging Neurosci , 9 :337 , 2017
Abstract :
PubMedSearch : Oguchi_2017_Front.Aging.Neurosci_9_337
PubMedID: 29089887

Title : Myasthenia gravis: Predictive factors associated with the synchronized elevation of anti-acetylcholine receptor antibody titer in Kanazawa, Japan - Iwasa_2014_J.Neuroimmunol_267_97
Author(s) : Iwasa K , Yoshikawa H , Samuraki M , Shinohara M , Hamaguchi T , Ono K , Nakamura H , Yamada M
Ref : Journal of Neuroimmunology , 267 :97 , 2014
Abstract :
PubMedSearch : Iwasa_2014_J.Neuroimmunol_267_97
PubMedID: 24388223

Title : Myasthenia gravis: Predictive factors associated with the synchronized elevation of anti-acetylcholine receptor antibody titer in Kanazawa, Japan - Iwasa_2014_J.Neuroimmunol_267_97
Author(s) : Iwasa K , Yoshikawa H , Samuraki M , Shinohara M , Hamaguchi T , Ono K , Nakamura H , Yamada M
Ref : Journal of Neuroimmunology , 267 :97 , 2014
Abstract :
PubMedSearch : Iwasa_2014_J.Neuroimmunol_267_97
PubMedID: 24388223

Title : Myasthenia gravis: Predictive factors associated with the synchronized elevation of anti-acetylcholine receptor antibody titer in Kanazawa, Japan - Iwasa_2014_J.Neuroimmunol_267_97
Author(s) : Iwasa K , Yoshikawa H , Samuraki M , Shinohara M , Hamaguchi T , Ono K , Nakamura H , Yamada M
Ref : Journal of Neuroimmunology , 267 :97 , 2014
Abstract :
PubMedSearch : Iwasa_2014_J.Neuroimmunol_267_97
PubMedID: 24388223

Title : REVIEW: Curcumin and Alzheimer's disease - Hamaguchi_2010_CNS.Neurosci.Ther_16_285
Author(s) : Hamaguchi T , Ono K , Yamada M
Ref : CNS Neurosci Ther , 16 :285 , 2010
Abstract :
PubMedSearch : Hamaguchi_2010_CNS.Neurosci.Ther_16_285
PubMedID: 20406252

Title : REVIEW: Curcumin and Alzheimer's disease - Hamaguchi_2010_CNS.Neurosci.Ther_16_285
Author(s) : Hamaguchi T , Ono K , Yamada M
Ref : CNS Neurosci Ther , 16 :285 , 2010
Abstract :
PubMedSearch : Hamaguchi_2010_CNS.Neurosci.Ther_16_285
PubMedID: 20406252

Title : REVIEW: Curcumin and Alzheimer's disease - Hamaguchi_2010_CNS.Neurosci.Ther_16_285
Author(s) : Hamaguchi T , Ono K , Yamada M
Ref : CNS Neurosci Ther , 16 :285 , 2010
Abstract :
PubMedSearch : Hamaguchi_2010_CNS.Neurosci.Ther_16_285
PubMedID: 20406252

Title : Presynaptic inhibitory effect of Met-enkephalin on [14C] acetylcholine release from the myenteric plexus and its interaction with muscarinic negative feedback inhibition - Vizi_1984_J.Pharmacol.Exp.Ther_230_493
Author(s) : Vizi ES , Ono K , Adam-Vizi V , Duncalf D , Foldes FF
Ref : Journal of Pharmacology & Experimental Therapeutics , 230 :493 , 1984
Abstract :
PubMedSearch : Vizi_1984_J.Pharmacol.Exp.Ther_230_493
PubMedID: 6747844

Title : Presynaptic inhibitory effect of Met-enkephalin on [14C] acetylcholine release from the myenteric plexus and its interaction with muscarinic negative feedback inhibition - Vizi_1984_J.Pharmacol.Exp.Ther_230_493
Author(s) : Vizi ES , Ono K , Adam-Vizi V , Duncalf D , Foldes FF
Ref : Journal of Pharmacology & Experimental Therapeutics , 230 :493 , 1984
Abstract :
PubMedSearch : Vizi_1984_J.Pharmacol.Exp.Ther_230_493
PubMedID: 6747844

Title : Presynaptic inhibitory effect of Met-enkephalin on [14C] acetylcholine release from the myenteric plexus and its interaction with muscarinic negative feedback inhibition - Vizi_1984_J.Pharmacol.Exp.Ther_230_493
Author(s) : Vizi ES , Ono K , Adam-Vizi V , Duncalf D , Foldes FF
Ref : Journal of Pharmacology & Experimental Therapeutics , 230 :493 , 1984
Abstract :
PubMedSearch : Vizi_1984_J.Pharmacol.Exp.Ther_230_493
PubMedID: 6747844